Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04091854Unknown

The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus

Role: lead

NCT04424706Unknown

The Effect and Mechanism of MMP-9 in Inducing Atherosclerosis

Role: lead

NCT03982238Phase 4Completed

Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients

Role: lead

NCT03983187Not ApplicableUnknown

Effect of Rotating Magnetic Therapy on Blood Glucose Spectrum of Type 2 Diabetic Patients With Glargine Therapy

Role: lead

NCT03983200Not ApplicableUnknown

Effect of Rotating Magnetic Therapy on Diabetic Peripheral Neuropathy

Role: lead

All 5 trials loaded